XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net earnings (loss) $ (509) $ (459)
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 1,442 1,669
Stock-based compensation 160 92
Realized (gain) loss on foreign currency forwards (34) (1)
(Gain) loss on equity securities 100  
Deferred income tax expense (benefit) (567) (369)
Goodwill and Intangible Asset Impairment 544  
Other noncash charges (credits), net 69 (110)
Changes in operating assets and liabilities    
Current and other assets (419) (501)
Payables and other liabilities 1,330 1,623
Net cash provided (used) by operating activities 2,116 1,944
Cash flows from investing activities:    
Capital expended for property and equipment and capitalized software (639) (532)
Purchases of short-term marketable securities and other investments (1,714) (1,713)
Sales of short-term marketable securities 1,692 921
Acquisitions by subsidiary, net of cash acquired (40) (169)
Other, net 41 8
Net cash provided (used) by investing activities (660) (1,485)
Cash flows from financing activities:    
Borrowings of debt 177 1,624
Repayments of debt (681) (594)
Shares issued by subsidiary 138 180
Shares repurchased by subsidiary (620) (154)
Dividends paid by subsidiary (117) (110)
Proceeds from exercise of equity awards and employee stock purchase plan 1 5
Taxes paid in lieu of shares issued for stock-based compensation   (9)
Other financing activities, net (65) (18)
Net cash provided (used) by financing activities (1,167) 924
Effect of foreign exchange rates on cash, and cash equivalents and restricted cash (119) 143
Net increase (decrease) in cash, and cash equivalents and restricted cash 170 1,526
Cash and cash equivalents and restricted cash at beginning of period 3,031 1,872
Cash and cash equivalents and restricted cash at end of period $ 3,201 $ 3,398